Integer Holdings Corporation (ITGR)
| Market Cap | 3.27B -16.8% |
| Revenue (ttm) | 1.86B +6.3% |
| Net Income | 141.80M +84.4% |
| EPS | 3.97 +82.2% |
| Shares Out | 33.95M |
| PE Ratio | 24.24 |
| Forward PE | 15.07 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 122,755 |
| Open | 97.04 |
| Previous Close | 96.31 |
| Day's Range | 96.09 - 98.14 |
| 52-Week Range | 62.00 - 116.31 |
| Beta | 0.64 |
| Analysts | Buy |
| Price Target | 100.00 (+3.95%) |
| Earnings Date | Aug 6, 2026 |
About ITGR
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, impl... [Read more]
Financial Performance
In 2025, Integer Holdings's revenue was $1.85 billion, an increase of 7.98% compared to the previous year's $1.72 billion. Earnings were $102.81 million, a decrease of -14.25%.
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for ITGR stock is "Buy." The 12-month stock price target is $100.0, which is an increase of 3.95% from the latest price.
News
Integer initiated with a Buy at Freedom Capital
Freedom Capital initiated coverage of Integer (ITGR) with a Buy rating and $112 price target The firm, which views Integer as a scaled and well-positioned specialty CDMO partner for large…
Integer price target raised to $110 from $97 at Truist
Truist raised the firm’s price target on Integer (ITGR) to $110 from $97 and keeps a Buy rating on the shares as part of a broader research note previewing Q2…
Integer price target raised to $96 from $92 at Citi
Citi raised the firm’s price target on Integer (ITGR) to $96 from $92 and keeps a Neutral rating on the shares. For Q2 earnings season, given “the skittish trading environment,”…
Integer Announces Conference Call to Discuss Second Quarter 2026 Results
PLANO, Texas, July 02, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), announced today t...
Integer Holdings Transcript: Truist Securities MedTech Conference 2026
A strategic review is underway, expected to conclude within months, with business continuity and customer relationships maintained. Guidance was revised due to EP market shifts and inventory adjustments, but no structural business changes are seen. Growth is expected to resume in late 2026, with disciplined cost management supporting financial targets.
Integer to Participate in Truist Securities 2026 MedTech Conference on June 16
PLANO, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced participation i...
Integer price target raised to $92 from $89 at Citi
Citi analyst Joanne Wuensch raised the firm’s price target on Integer (ITGR) to $92 from $89 and keeps a Neutral rating on the shares. The firm updated models in the…
Oppenheimer upgrades Integer to Outperform as checks suggest PE CMO interest
As previously reported, Oppenheimer analyst Suraj Kalia upgraded Integer (ITGR) to Outperform from Perform with a $115 price target The firm notes Integer recently announced a strategic review process...
Integer upgraded to Outperform from Perform at Oppenheimer
Oppenheimer upgraded Integer (ITGR) to Outperform from Perform with a $115 price target
Integer Holdings Transcript: Bank of America Global Healthcare Conference 2026
Outsourcing trends and technical expertise support a strong market position, while a strategic review is underway due to increased external interest. Guidance was lowered for 2024 mainly due to short-term EP product adjustments, but robust diversification, margin improvement plans, and a growing pipeline underpin confidence in long-term growth.
Integer price target lowered to $89 from $92 at Citi
Citi lowered the firm’s price target on Integer (ITGR) to $89 from $92 and keeps a Neutral rating on the shares.
Integer price target raised to $98 from $91 at BofA
BofA analyst Craig Bijou raised the firm’s price target on Integer (ITGR) to $98 from $91 and keeps a Neutral rating on the shares. Despite the Q1 revenue beat, the…
Integer initiates strategic review
Integer (ITGR) announced that its board of directors has initiated a strategic review. In consultation with its financial and legal advisors, the board will consider a full range of potential…
Integer Holdings Earnings Call Transcript: Q1 2026
Q1 2026 results met expectations with modest sales growth but lower margins and EPS. 2026 guidance was revised downward due to temporary headwinds in electrophysiology and risk adjustments, while a strategic review was launched amid increased external interest.
Integer Holdings Slides: Q1 2026
Integer Holdings has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
Integer Holdings Earnings release: Q1 2026
Integer Holdings released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Integer Holdings Quarterly report: Q1 2026
Integer Holdings has published its Q1 2026 quarterly earnings report on April 30, 2026.
Integer Holdings Corporation Reports First Quarter 2026 Results
~ First quarter results in line with February outlook ~ ~ Updates 2026 outlook ranges; continues to expect 200bps above-market organic sales growth in 2027 ~ PLANO, Texas, April 30, 2026 (GLOBE NEWSWI...
Integer Announces Strategic Review to Maximize Stockholder Value
PLANO, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced ...
Integer to Participate in Bank of America Healthcare Conference on May 12
PLANO, Texas, April 29, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced participation ...
Integer chair Pamela Bailey to step down, Donald Spence to succeed
Integer (ITGR) announced Pamela Bailey, who currently serves as Integer’s independent chair of the board, will not stand for re-election at the company’s 2026 annual meeting of stockholders, scheduled...
Integer Announces Board Leadership Transition
PLANO, Texas, April 06, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced ...
Integer Holdings Proxy statement: Proxy filing
Integer Holdings filed a proxy statement on April 6, 2026, providing details for shareholder voting and corporate governance matters.
Integer Holdings Proxy statement: Proxy filing
Integer Holdings filed a proxy statement on April 6, 2026, providing details for shareholder voting and corporate governance matters.
Integer Announces Conference Call to Discuss First Quarter 2026 Results
PLANO, Texas, April 02, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), announced today ...